Clinuvel Pharmaceuticals Limited (CLVLY)
ValueMarkers Composite Index
54% below intrinsic value ($9)
Clinuvel Pharmaceuticals Limited (CLVLY) — VMCI valuation read
CLVLY prints VMCI 70/100 inside the Healthcare sector, where the median sits at 50. The 20-point above-median delta is the cleanest single-number summary of Clinuvel Pharmaceuticals Limited's composite stance, and in the mid-cap bucket it places the share ahead of the typical peer on the five-pillar mix.
On CLVLY, the SEC EDGAR Form 4 stream shows no insider buys or sells in the past 30 days. Quiet tapes happen; they just remove a signal that bull and bear cases sometimes lean on for confirmation.
**Investor frame.** CLVLY trades at 22.0x earnings, 22% above the Healthcare median of 18.0x; that is the value line. ROIC of 10.0% sits 0.0pp above the Healthcare median (10.0%); that is the quality line. net debt to EBITDA of 0.9x leaves covenant headroom; that is the risk line for Clinuvel Pharmaceuticals Limited on the trailing financials.
CLVLY rose 2.1% over the trailing 7 days, with a -22.0% read on a 30-day basis.
Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue; Parvysmelanotide (VLRX001), which provoke increased and prolonged cellular activity; and PRÉNUMBRA, a liquid injectable formulation of afamelanotide. Clinuvel Pharmaceuticals Limited has a collaboration agreement with HK Winhealth Pharma Group Co. Limited t to treat EPP patients with SCENESSE under a named patient program in the People's Republic of China. The company was founded in 1987 and is headquartered in Melbourne, Australia.
Related Stocks in Healthcare
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.